You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

wAMD

Showing 1 - 25 of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular (Wet) Age-related Macular Degeneration (nAMD) Trial (EXG102-031)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration (nAMD)
  • EXG102-031
  • (no location specified)
Jun 13, 2023

Wet Age-related Macular Degeneration Trial (Ranibizumab, SCT510A)

Not yet recruiting
  • Wet Age-related Macular Degeneration
  • (no location specified)
Jul 28, 2022

s in Wet Age-related Macular Degeneration Which Have Never

Active, not recruiting
  • Wet Age-related Macular Degeneration
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, Argentina
  • +16 more
Jan 16, 2023

Age Related Macular Degeneration Trial in Xuzhou (recombinant anti-vascular endothelial growth factor (VEGF) humanized mAb

Recruiting
  • Age Related Macular Degeneration
  • recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
  • Xuzhou, Jiangsu, China
    XuZhou Central Hospital
Feb 7, 2022

Age Related Macular Degeneration Trial in Nedlands (HLX04-O, ranibizumab)

Recruiting
  • Age Related Macular Degeneration
  • Nedlands, Western Australia, Australia
    Lions Eye Institute
Feb 7, 2022

Wet Age-related Macular Degeneration Trial in Bern (Aflibercept, Brolucizumab, early treat and extend (T&E))

Enrolling by invitation
  • Wet Age-related Macular Degeneration
  • Bern, Switzerland
    Berner Augenklinik am Lindenhofspital
May 13, 2022

Wet Macular Degeneration Trial in Germany, United Kingdom, United States (BI 836880)

Suspended
  • Wet Macular Degeneration
  • BI 836880
  • Palo Alto, California
  • +13 more
Aug 24, 2022

Neovascular Age-related Macular Degeneration Trial in Italy (Brolucizumab)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Ancona, AN, Italy
  • +18 more
Aug 10, 2022

Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)

Terminated
  • Wet Age-related Macular Degeneration
  • +2 more
  • Phoenix, Arizona
  • +10 more
Nov 1, 2022

Wet Age-related Macular Degeneration Trial in Beijing (Aflibercept)

Completed
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 19, 2022

Wet Age-related Macular Degeneration Trial in United States (Eyp-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)

Recruiting
  • Wet Age-related Macular Degeneration
  • Melbourne, Florida
  • +4 more
Aug 18, 2022

Use of Aflibercept Injections Into Eye for Treatment of Eye

Recruiting
  • Retinal Disease
  • Aflibercept (BAY86-5321, Eylea)
  • Multiple Locations, Mexico
    Many locations
Aug 22, 2022

Wet Age-related Macular Degeneration Trial in United States (EYP-1901)

Completed
  • Wet Age-related Macular Degeneration
  • Phoenix, Arizona
  • +10 more
Jul 25, 2022

Age Related Macular Degeneration Trial in China (HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized

Recruiting
  • Age Related Macular Degeneration
  • HLX04-O，recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
  • Lucentis
  • Bengbu, Anhui, China
  • +40 more
Apr 27, 2022

Age Related Macular Degeneration Trial (LY09004, Eylea)

Not yet recruiting
  • Age Related Macular Degeneration
  • (no location specified)
Sep 25, 2020

AMD, nAMD, Wet Age-related Macular Degeneration Trial in United States (RGX-314 Dose 1, RGX-314 Dose 2, Aflibercept (EYLEA®))

Recruiting
  • AMD
  • +5 more
  • RGX-314 Dose 1
  • +2 more
  • Encino, California
  • +16 more
Jun 2, 2022

Wet Age-related Macular Degeneration Trial in Puerto Rico, United States (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Wet Age-related Macular Degeneration
  • Phoenix, Arizona
  • +65 more
Jun 2, 2022

RGX-314 Administered in the Suprachoroidal Space for nAMD

Enrolling by invitation
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • +5 more
  • No intervention.
  • Phoenix, Arizona
  • +14 more
Jan 14, 2022

Wet Age-related Macular Degeneration Trial (SCT510A)

Not yet recruiting
  • Wet Age-related Macular Degeneration
  • (no location specified)
Sep 21, 2020

Wet Age-related Macular Degeneration Trial in Hungary (ALK4290)

Completed
Has Results
  • Wet Age-related Macular Degeneration
  • Budapest, Hungary
  • +4 more
Nov 30, 2020

Wet Age-related Macular Degeneration Trial in Hungary (ALK4290)

Completed
Has Results
  • Wet Age-related Macular Degeneration
  • Budapest, Hungary
  • +4 more
Nov 23, 2020

Wet Age-related Macular Degeneration Trial in Beijing (Drug 601)

Unknown status
  • Wet Age-related Macular Degeneration
  • Drug 601
  • Beijing, China
    BeiJing Hospital
Jul 8, 2020

Age-Related Macular Degeneration Trial in Wuhan (CM082)

Unknown status
  • Age-Related Macular Degeneration
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University, Hubei General Hospital
Jan 8, 2020

Age-Related Macular Degeneration Trial in China (CM082 tablet)

Suspended
  • Age-Related Macular Degeneration
  • CM082 tablet
  • Beijing, Beijing, China
  • +5 more
Jan 8, 2020

Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

Not yet recruiting
  • Age-Related Macular Degeneration
  • NG101 AAV gene therapy
  • Toronto, Ontario, Canada
    Vitreous Retina Macula Specialists of Toronto
Aug 2, 2023